ENDRA Life Sciences
NDRA
•
NASDAQ
•
52W Range | $2.90-$170.62 |
Market Cap | $5.9M |
Shares Short | 15,787 |
Revenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | $390.78 |
Yahoo Finance • a year ago
CEO | Mr. Alexander Y. Tokman |
CFO | Mr. Richard Jacroux |
Address | 3600 Green Court, Ann Arbor, MI, United States, 48105-1570 |
Sector | Healthcare |
Industry | Diagnostics & Research |
Full-Time Employees | 21 |